England stands at the edge of a rare public health triumph: the near-elimination of hepatitis C, a virus that has long hidden silently in the bodies of those it harms most. Over a decade of systematic testing, accessible treatment, and deliberate outreach have transformed a once-invisible epidemic into a measurable, retreating threat. Where medicine once lacked the tools, it now possesses a cure effective in over 95% of cases — and the harder work of finding those who do not yet know they are ill is nearly complete. The World Health Organization set 2030 as the horizon; England may cross it ea
England on track to eliminate hepatitis C ahead of 2030 WHO target
Hepatitis C causes serious liver damage and death if untreated; the disease has claimed lives preventable through early diagnosis and treatment.
A virus that hides in the body for years is being hunted down through systematic testing
Mark
Why does it matter that England reaches this target before 2030? Isn't the virus being eliminated either way?
Mimi
The difference is time and lives. Every year someone carries untreated hepatitis C is a year their liver is being damaged. If England finishes the job in 2027 instead of 2030, that's three more years of people living without the threat of liver failure or death. It's also a signal to other countries that elimination is actually possible.
Mark
You mention that 84.6% of cases are diagnosed, but 15% are still out there. Who are these people and why haven't they been found?
Mimi
Many of them don't know they have it. Hepatitis C is silent—no symptoms, no warning signs. Some were infected decades ago through medical procedures or blood transfusions before screening existed. Others may be in communities where trust in health services is lower, or where language barriers make outreach harder. That's why the NHS is specifically targeting people from Eastern Europe, where infection rates from older medical practices were higher.
Mark
The treatment sounds almost miraculous—95% cure rate in 8 to 12 weeks. Why wasn't this solved years ago?
Mimi
The medicine is recent. These antiviral drugs only became available in the last decade or so. Before that, treatment was much harder and less effective. But even with good medicine, you can't cure people you don't know exist. The real breakthrough has been the testing infrastructure—home kits, GP screening, A&E blood tests. You have to find them first.
Mark
What happens to someone like Paul Eatwell after he's cured? Is he truly free of the virus?
Mimi
Yes. Once the antivirals clear the infection, it's gone. The liver damage that's already happened doesn't reverse, but the virus stops destroying more tissue. If he'd been diagnosed earlier, before significant damage occurred, he'd have a normal lifespan ahead. That's why finding people early matters so much.
Mark
Is there a risk that England declares victory too early and stops testing?
Mimi
That's the real danger. The NHS is saying they want to finish the job, but momentum can fade. If funding shifts or attention moves to other diseases, those final 15% of undiagnosed cases could slip through. Elimination means actually eliminating it, not just treating most of it.
Il Polso
- A virus that causes no symptoms for years has quietly damaged the livers of tens of thousands — many of whom had no idea they were infected until systematic outreach found them.
- England has already surpassed the 80% treatment target and cut hepatitis C deaths by more than a third in a decade, signalling a campaign that is genuinely working.
- Free home testing kits, A&E blood tests, and GP registration screening have dismantled the barriers that once kept diagnosis out of reach for the most vulnerable.
- Roughly 50,200 people are still estimated to be living with the virus, and the remaining undiagnosed cases are concentrated in specific communities — particularly adults from Eastern Europe who may have been exposed before 1991 safety protocols existed.
- The NHS is actively reaching into those communities now, with the 90% diagnosis target and the 2030 WHO elimination deadline both within striking distance.
England stands at the edge of a rare public health triumph: the near-elimination of hepatitis C, a virus that has long hidden silently in the bodies of those it harms most. Over a decade of systematic testing, accessible treatment, and deliberate outreach have transformed a once-invisible epidemic into a measurable, retreating threat. Where medicine once lacked the tools, it now possesses a cure effective in over 95% of cases — and the harder work of finding those who do not yet know they are ill is nearly complete. The World Health Organization set 2030 as the horizon; England may cross it early.
England is within reach of becoming one of the first nations to eliminate hepatitis C — a public health milestone that would represent one of the country's most significant medical achievements. Deaths from the virus have fallen by more than a third over the past decade, and the treatment target of reaching 80% of known cases has already been surpassed. The WHO set 2030 as the global deadline for elimination. England appears likely to arrive ahead of it.
What makes this moment remarkable is the nature of the disease itself. Hepatitis C spreads through infected blood — shared needles, old transfusions, contaminated equipment — but carries no obvious symptoms for years, accumulating silent damage in the liver. The cure, when it came, was decisive: eight to twelve weeks of antiviral tablets resolve more than 95% of infections. The challenge was never the medicine. It was locating the people who needed it.
Since 2015, the NHS has diagnosed and treated more than 100,000 people. The strategy was deliberately broad — blood tests in A&E departments, screening at GP registration, and free home testing kits requiring nothing more than an online order. These measures have drawn thousands out of unknowing infection, people who felt entirely well and might never have discovered the virus until serious harm was done.
Around 50,200 adults in England are currently estimated to be living with hepatitis C, and 84.6% have now been identified — approaching the 90% target that signals near-complete case detection. The remaining undiagnosed cases tend to cluster in particular communities, especially adults from Eastern European countries who may have been exposed through medical or dental procedures before screening protocols were established in 1991. The NHS is reaching out to these groups directly, offering the same free, confidential testing.
For Paul Eatwell, a 65-year-old grandfather from Blackburn, the discovery came through a routine blood test. He felt well, had no symptoms, and could not immediately account for how the virus had entered his body — possibly through surgery abroad decades earlier. What stayed with him was not the shock of diagnosis but the quality of care that followed, which turned a frightening moment into a navigable one.
The story of England's progress against hepatitis C is ultimately one of infrastructure confronting invisibility — a hidden disease being systematically found, treated, and tracked toward extinction. If the momentum holds and the remaining cases are reached, the WHO's 2030 target will not be a finish line England crosses. It will be one it has already passed.
England is within reach of becoming one of the world's first nations to eliminate hepatitis C entirely—a milestone that would rank among the country's most significant public health victories. The evidence is already there: the treatment target of reaching 80% of all known cases has been surpassed, and deaths from the virus have dropped by more than a third over the past decade. The World Health Organization set 2030 as the deadline for global elimination. England appears poised to arrive early.
The virus itself is deceptively quiet. Hepatitis C spreads through contact with infected blood—shared needles, contaminated medical equipment, transfusions before screening protocols existed—but many people carry it for years without knowing. The damage accumulates silently in the liver until, untreated, it becomes severe enough to threaten life. What makes the current moment significant is that the disease is no longer a death sentence. Eight to twelve weeks of antiviral tablets cure more than 95% of infections. The hard part was never the medicine. It was finding the people who had it.
Since 2015, the NHS has diagnosed and treated more than 100,000 people with hepatitis C. That figure alone represents a transformation in case detection. The strategy has been deliberately broad: blood tests offered in accident and emergency departments, screening through GP registration, and free home testing kits that require no conversation with a doctor, no appointment, no barrier beyond ordering online. These initiatives have pulled thousands of people out of the shadows—individuals who had no idea they were infected, who felt fine, who might never have discovered the virus until it had done irreversible damage.
Current estimates suggest that roughly 50,200 adults in England are living with hepatitis C. Of those, 84.6% have now been diagnosed, approaching the 90% target that would signal near-complete case identification. The mortality reduction target—a 65% drop compared with 2015 levels—has not yet been met, but the trajectory suggests it will be before 2030. The Hepatitis C Trust has described England as standing on the threshold of one of the country's most remarkable public health achievements.
Professor Frankie Swords, the NHS's national medical director, framed the moment as both accomplishment and unfinished work: England is leading the world in the push to eliminate the disease and is on course to beat the WHO deadline, but the job is not done. The remaining cases tend to cluster in specific populations. Adults born in Eastern European countries—Ukraine, Romania, Estonia, Latvia, Poland, Albania, Lithuania, Bulgaria, Czechia, and Slovakia—are being urged to test. Some may have contracted hepatitis C through medical or dental procedures before 1991, when screening and safety protocols were less rigorous. The NHS is actively reaching out to these groups, offering the same free, confidential home testing kits.
Paul Eatwell, a 65-year-old grandfather from Blackburn in Lancashire, discovered his infection through a routine blood test. His initial reaction was disbelief—he felt well, had no symptoms, could not immediately explain how the virus had entered his body. It may have come from surgery in South Africa decades earlier, though the exact source remains unclear. What struck him was not the diagnosis itself but the quality of medical support that followed. The care made the difference between a frightening discovery and a manageable path forward.
The story of hepatitis C elimination in England is ultimately a story about infrastructure meeting invisibility. A virus that hides in the body for years, causing no warning signs, is being hunted down through systematic testing, treated with pills that work, and tracked through data that shows progress. The WHO's 2030 target is no longer a distant goal. It is something England may reach years ahead of schedule—if the momentum holds and the remaining undiagnosed cases are found.
Citazioni salienti
England is now leading the world in the mission to eliminate this disease and on course to beat the WHO's 2030 target, but we are determined to keep up the momentum and finish the job.— Professor Frankie Swords, NHS national medical director
My first reaction was disbelief. I didn't feel ill. I kept wondering how I could possibly have caught it.— Paul Eatwell, 65, diagnosed after routine blood test
Vuoi la storia completa?
Leggi l'originale su BBC News ↗
Health & Medicine